Insider · SEC Form 4 filer

OrbiMed Capital GP VII LLC

Companies

Where they file as an insider

Electra Therapeutics (ETRA) Director, 10% owner Latest filing Sep 21, 2026
Q32 Bio (QTTB) Director, 10% owner Latest filing May 28, 2026
Passage BIO (PASG) 10% owner Latest filing Apr 17, 2025
Lomond Therapeutics Director Latest filing Nov 1, 2024
Enliven Therapeutics (ELVN) Director, 10% owner Latest filing May 16, 2024

Track record

Did their buys beat the typical stock?

Open-market buys4
Quarters checked 6 months later0
Beat the typical stock —
Quarters too new to check2

Too soon to tell. None of their buys has a finished 6-month check yet.

Electra Therapeutics (ETRA) Bought Sep 21, 2026 · $20M · 1.33M shares Too new Too new. Its 6-month check uses prices as of Mar 31, 2027.
Q32 Bio (QTTB) Bought May 28, 2026 · $15M · 1.88M shares Too new Too new. Its 6-month check uses prices as of Dec 31, 2026.

Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.

Past results. This is data, not advice.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist